Abstract Track record and aims: The decreased action of incretin hormones in form 2 diabetes (T2D) is mainly attributed to GIP insensitivity, but efficacy estimates of GIP and GLP-one differ amongst experiments, as well as negligible effects of pharmacological GIP doses remain unexplained. We aimed to characterize incretin action in https://du-h-c-ti-ng-anh-t-i-phil96395.affiliatblogger.com/67528342/the-duhocphilippines-vn-diaries